Literature DB >> 18313989

Psychiatric comorbidity in epilepsy: a study comparing patients with mesial temporal sclerosis and juvenile myoclonic epilepsy.

Gerardo Maria de Araújo Filho1, Vivianne Pellegrino Rosa, Katia Lin, Luís Otávio Sales Ferreira Caboclo, Américo Ceiki Sakamoto, Elza Márcia Targas Yacubian.   

Abstract

We evaluated the frequency of psychiatric disorders (PDs) in a homogenous series of patients with temporal lobe epilepsy with mesial temporal sclerosis (TLE-MTS), as compared with patients with juvenile myoclonic epilepsy (JME), aiming to determine possible differences in psychiatric diagnoses between these two epileptic syndromes. Data from 170 patients with refractory TLE-MTS and from 100 patients with JME were reviewed and compared. The prevalence of PDs was high in both groups of patients with epilepsy: PDs were present in 85 patients with TLE-MTS (50%) and 49 patients with JME (49%). Among the TLE-MTS group, mood (25.8%), psychotic (15.8%), and anxiety (14.1%) disorders were the most frequent diagnoses, whereas anxiety and mood disorders (23 and 19%, respectively) were the most common among patients with JME. Psychoses were significantly associated with MTS (P<0.01) and anxiety disorders with JME (P<0.05). These findings suggest the existence of an anatomic correlation between PDs and brain structures involved in both epilepsy syndromes.

Entities:  

Mesh:

Year:  2008        PMID: 18313989     DOI: 10.1016/j.yebeh.2008.01.008

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  9 in total

Review 1.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

2.  The Timing, Nature, and Range of Neurobehavioral Comorbidities in Juvenile Myoclonic Epilepsy.

Authors:  Dace N Almane; Jana E Jones; Taylor McMillan; Carl E Stafstrom; David A Hsu; Michael Seidenberg; Bruce P Hermann; Temitayo O Oyegbile
Journal:  Pediatr Neurol       Date:  2019-03-19       Impact factor: 3.372

Review 3.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 4.  A Systematic Review of Psychiatric and Psychosocial Comorbidities of Genetic Generalised Epilepsies (GGE).

Authors:  A Loughman; N A Bendrups; W J D'Souza
Journal:  Neuropsychol Rev       Date:  2016-10-10       Impact factor: 7.444

5.  Comprehensive analysis of presurgical factors predicting psychiatric disorders in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis underwent cortico-amygdalohippocampectomy.

Authors:  Wei Yang; Chongyi Chen; Bo Wu; Qiaoyu Yang; Dongdong Tong
Journal:  J Clin Lab Anal       Date:  2018-12-05       Impact factor: 2.352

6.  Major Depressive Disorder Associated With Reduced Cortical Thickness in Women With Temporal Lobe Epilepsy.

Authors:  Mateus Henrique Nogueira; Luciana Ramalho Pimentel da Silva; José Carlos Vasques Moreira; Thiago Junqueira Ribeiro de Rezende; Tamires Araújo Zanão; Brunno Machado de Campos; Clarissa Lin Yasuda; Fernando Cendes
Journal:  Front Neurol       Date:  2020-01-17       Impact factor: 4.003

Review 7.  Temporal Lobe Epilepsy and Psychiatric Comorbidity.

Authors:  Valerio Vinti; Giovanni Battista Dell'Isola; Giorgia Tascini; Elisabetta Mencaroni; Giuseppe Di Cara; Pasquale Striano; Alberto Verrotti
Journal:  Front Neurol       Date:  2021-11-30       Impact factor: 4.003

8.  Juvenile myoclonic epilepsy: Clinical characteristics, standard and quantitative electroencephalography analyses.

Authors:  Sai Krishna Tikka; Nishant Goyal; Shreekantiah Umesh; Shamsul Haque Nizamie
Journal:  J Pediatr Neurosci       Date:  2013-05

Review 9.  The prevalence of psychosis in epilepsy; a systematic review and meta-analysis.

Authors:  Maurice J Clancy; Mary C Clarke; Dearbhla J Connor; Mary Cannon; David R Cotter
Journal:  BMC Psychiatry       Date:  2014-03-13       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.